-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0277_03-10-2008.pdf
January 01, 2008 - populations, interventions,
comparators, and outcomes, will be further developed in the refinement phase … The diseases covered in the AHRQ review will be defined during the refinement
phase.
-
effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
September 01, 2015 - The “track-only” designation means that the intervention is in late-phase
trials, but late-phase data … All topics proceed through Phase 1. … Phase 2. … Phase 1 – Internal Expert Comment and Triage (all topics)
In Phase 1. … Phase 2 – External Expert Comment
Select topics enter Phase 2.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
September 01, 2015 - The “track-only” designation means that the intervention is in late-phase
trials, but late-phase data … All topics proceed through Phase 1. … Phase 2. … Phase 1 – Internal Expert Comment and Triage (all topics)
In Phase 1. … Phase 2 – External Expert Comment
Select topics enter Phase 2.
-
effectivehealthcare.ahrq.gov/products/quality-rating/research
November 01, 2011 - A Process for Robust and Transparent Rating of Study Quality: Phase 1
Research Report November 1, 2011 … Purpose
To complete the first phase of a project to develop such a methodology, we aimed to examine
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendixes-surveillance-report-1-nonopioid-trtmts-chronic-pain.pdf
January 01, 2021 - Efficacy and safety of fasinumab in
patients with chronic low back pain:
a phase II/III randomised … in patients with knee pain due to
osteoarthritis: an exploratory post
hoc analysis of a Japanese phase … or chronic
low back pain with early pain
reduction: an exploratory post-hoc
analysis of Japanese phase … Open-label phase 3 study of
diclofenac conjugated to hyaluronate
(diclofenac etalhyaluronate: ONO- … [TM]s effect
in Chinese patients with chronic pain
due to osteoarthritis: post hoc
analyses of a phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/survival-quality_research.pdf
April 01, 2013 - capecitabine
alone
HRQL analysis of Cameron
2008, phase III,
randomized, open-label,
multicenter … Is this study
A) a phase III (RCT) trial
B) does it address one of the combinations below:
AND … Schetelig
Level: 2, State: Excluded
Refid: 1588, Independent radiologic review of OCEANS, a phase … Vahdat
Level: 2, State: Excluded
Refid: 1600, Phase II escalation study of sorafenib in patients … Mahner
Level: 2, State: Excluded
Refid: 1630, A Randomized, Phase II Trial of Standard Triweekly
-
effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1412.pdf
December 22, 2014 - Results
The table below lists the eight topics for which (1) preliminary phase III data on drugs, phase … A number of other manufacturers also have all-oral HCV regimens in
phase II or phase III development … Sofosbuvir and RBV regimens: In phase III trials, patients infected with HCV genotypes
2 and 3 who … Daclatasvir/sofosbuvir: In a phase II, open-label randomized controlled trial, patients
with chronic … In the phase III, randomized controlled VALENCE trial, patients (n=419) with chronic HCV
genotype 2
-
effectivehealthcare.ahrq.gov/products/medicare-medication-use/research
April 23, 2014 - In addition, the existence of a Part D coverage gap before reaching the catastrophic coverage phase can
-
effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
January 01, 2012 - Results
The table below lists the three topics for which (1) preliminary phase III or later data were … available for drugs or phase II, III, or later data were available for devices and procedures; (2) … Another drug, roflumilast, failed to meet its primary endpoints in a just-completed
phase III trial … The drug is in several phase III clinical trials cosponsored by the Cystic Fibrosis
Foundation. … Vertex corrects and provides additional data
from recent interim analysis of phase 2
combination
-
effectivehealthcare.ahrq.gov/products/grant-manuscripts/underperformance-abstract
-
effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
January 01, 2012 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in
phase … Results
The table below lists the one topic in the system for which (1) preliminary phase III or later … In a randomized, double-blind,
placebo-controlled, phase III clinical trial, cosponsored by the Cystic … Vertex Pharmaceuticals initiates phase 3 registration
program for VX-770, an oral CFTR potentiator … Final data from phase 2 combination study of VX-
809 and Kalydeco (ivacaftor) showed statistically
-
effectivehealthcare.ahrq.gov/sites/default/files/substanceabuse_hi_impact.pdf
January 01, 2012 - III trials
for pharmaceuticals or biotechnologies or in phase II or a trial with some preliminary … The table below lists the eight topics for which (1) preliminary phase III data
were available for … The
buprenorphine implant is currently in two phase III trials, one of which is funded by the
National … Titan Pharmaceuticals presents phase 3
probuphine data at society for Neuroscience
annual meeting … Titan Pharmaceuticals announces positive top
line results in confirmatory phase 3 trial of
probuphine
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0210_12-07-2009.pdf
January 01, 2009 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase … cognitive rehabilitation therapies, neurorehabilitation, and/or medication used during the non-
acute phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-translation-c-diff-treatment-clinical-pathway.pdf
November 01, 2019 - Details for
each phase and associated tasks are presented in Table 2. … design phase). … Minimal changes were required during the review
phase of the order set prototype. … Group Recommendation Statements by Clinical Phase and Target CDS Channel
Task 4. … Categorize Recommendation Statements by Clinical Phase
Task 4.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/single-group-studies_white-paper.pdf
January 01, 2013 - active treatments so that they could proceed to phase 3 investigations. … Comparison of error rates in single-arm versus
randomized phase II cancer clinical trials. … Incorporating historical
control data in planning phase II clinical trials. … for definitive
phase III testing. … Quantitative evaluation of
single-arm versus randomized phase II cancer
clinical trials.
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
October 01, 2014 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in
phase … Results
The table below lists the five topics for which (1) preliminary phase III data on drugs or phase … Paul, MN) are in phase III development for DBS for
treating MDD. … III
clinical trial.7 Three completed phase III trials did not demonstrate superiority of mifepristone … .16 In phase 1, using local anesthesia, a neurosurgeon drills into the patient’s skull and
places the
-
effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_june_2012.pdf
January 01, 2012 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in
phase … Results
The table below lists the three topics for which (1) preliminary phase III data for drugs, phase … -based phase III trials are ongoing for flutemetamol, and the
manufacturer anticipates a premarket … exhibiting raised and normal beta-amyloid levels.
10
Flutemetamol is being investigated in two phase … Phase
1 study of the Pittsburgh compound B derivative
18F-flutemetamol in healthy volunteers and
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0663-131114.pdf
April 10, 2013 - populations, interventions, comparators, and
outcomes, will be further developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
January 01, 2014 - Results
The table below lists the six topics for which (1) preliminary phase III or later phase data … Phase III trial results are expected in late 2011 and 2012. … The company started phase III trials of a subcutaneous formulation in December
2011. … Pfizer's tofacitinib meets endpoints in final
phase III trials. … Trial watch: BLYS-targeted
antibody shows promise in Phase III SLE trial.
-
effectivehealthcare.ahrq.gov/sites/default/files/study-eligibility-criteria-quiz.ppt
September 02, 2013 - Study Eligibility Criteria Interactive Quiz
Study Eligibility Criteria
Interactive Quiz
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
Study Eligibility Criteria Interactive Quiz
This interactive quiz augments the module on st…